SILVER SPRING, Md. — The Food and Drug Administration has approved Aurobindo’s generic of Micardis HCT (telmisartan and hydrochlorothiazide) tablets, the company announced Friday.
The drug is indicated to treat hypertension and had a market size of $81.9 million for the 12 months ended November 2016, according to QuintilesIMS data.
Aurobindo’s generic will be available in dosage strengths of 40 mg telmistartan/12.5 mg hydrochlorothiazide, 80 mg telmisartan/12.5 mg hydrochlorothiazide and 8- mg telmisartan/25 mg hydrochlorothiazide.
January 20, 2017 | By David Salazar